IBI Ag announced the completion of its Series A funding round totaling $10 million, marking a significant step forward in advancing the company’s bioinsecticide platform. Corteva led the round through its Corteva Catalyst platform, alongside participation from The Trendlines Group, Iron Nation, Consensus Business Group, and a grant from the Israel Innovation Authority. Bandera Capital and First Imagine Ventures joined the round to support its completion.
The funding represents growing market interest in next-generation agricultural biologicals and reflects increased demand for sustainable alternatives to conventional chemical crop protection. The capital will enable IBI Ag to accelerate product development and regulatory progress for its platform, which is built around single-domain antibodies, also known as nanobodies.
IBI Ag’s technology introduces novel modes of action designed to protect high-value crops from a broad range of insect pests. The products are engineered to be selective and environmentally safe, reducing harm to beneficial insects while improving farmer productivity. The company’s approach adapts antibody-based principles, historically used in pharmaceuticals, to agricultural applications, delivering targeted insect control with a reduced ecological footprint.
The company and Corteva have continued to expand their collaboration through the Corteva Catalyst platform. The platform is focused on working with early-stage innovators to speed the development and deployment of sustainable agricultural and food system technologies.
KEY QUOTES:
“We’re proud to have the continued confidence of our investors and to welcome Bandera Capital and First Imagine Ventures to the IBI Ag family. With the completion of our Series A, we are well positioned to bring our novel biological solutions closer to farmers worldwide, supporting both productivity and sustainability.”
Arnon Heyman, Chief Executive Officer, IBI Ag
“The collaboration between IBI Ag and Corteva is a clear example of how working together can deliver innovation that increases performance and provides more sustainable solutions in crop protection. We are excited to continue exploring the development of next generation biologicals and naturally inspired solutions as IBI Ag advances toward commercialization.”
Tom Greene, Senior Director at Corteva and Global Leader for Corteva Catalyst
